2017
DOI: 10.1007/s00101-017-0381-6
|View full text |Cite
|
Sign up to set email alerts
|

Medikamente zur intravenösen Narkoseinduktion: Etomidat

Abstract: The pharmacological and historical knowledge about the currently available intravenous induction hypnotics form the basis for the daily work of anesthetists. Side effects of using hypnotic induction agents must be anticipated and adequately treated. Decades of experience with using intravenous induction hypnotics have led to theoretical requirements for an ideal narcotic agent with a best possible side effect profile. In the absence of this optimal hypnotic induction agent, a careful selection of one or a comb… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 43 publications
0
3
0
1
Order By: Relevance
“…It has a favorable hemodynamic profile on induction, with minimal blood pressure depression, therefore being ideal for shock trauma, hypovolemic patients or patients with significant cardiovascular disease [91].…”
Section: Administration and Dosage Regimenmentioning
confidence: 99%
“…It has a favorable hemodynamic profile on induction, with minimal blood pressure depression, therefore being ideal for shock trauma, hypovolemic patients or patients with significant cardiovascular disease [91].…”
Section: Administration and Dosage Regimenmentioning
confidence: 99%
“…Etomidate has a favorable hemodynamic profile upon induction, causing the minimal depression of blood pressure. This makes it particularly suitable for use in shock trauma patients, those with hypovolemia, or individuals with significant cardiovascular disease [88]. For procedural sedation and analgesia (PSA) in adults, etomidate is administered intravenously over 30 to 60 s at doses of 0.1 to 0.15 mg/kg, which is lower than the dose typically used for rapid sequence intubation.…”
Section: Administration and Dosage Regimenmentioning
confidence: 99%
“…Die kardiopulmonale Belastbarkeit ist zur Gesamt-Risikoeinschätzung notwendig. Aussagekräftig und in den Leitlinien zur Risikostratifizierung gefordert [3] [8]. Eine Nebennierenrindensuppression ist (für einen Zeitraum von mindestens 6-8 Stunden) beschrieben [9].…”
Section: Kardiopulmonale Belastbarkeitunclassified